Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKD1 | Q15139 | 2/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 1.00 |
| ▸ | PRKACA | P17612 | 10/20 | 0.78 |
| ▸ | PRKACG | P22612 | 10/20 | 0.78 |
| ▸ | PRKACB | P22694 | 10/20 | 0.78 |
| ▸ | GSK3B | P49841 | 5/20 | 0.78 |
| ▸ | CDK4 | P11802 | 3/20 | 0.78 |
| ▸ | CCND1 | P24385 | 3/20 | 0.78 |
| ▸ | PRKCA | P17252 | 3/20 | 0.78 |
| ▸ | CCNB2 | O95067 | 3/20 | 0.78 |
| ▸ | CDK1 | P06493 | 3/20 | 0.78 |
| ▸ | CCNB1 | P14635 | 3/20 | 0.78 |
| ▸ | CCNB3 | Q8WWL7 | 3/20 | 0.78 |
| ▸ | PIM1 | P11309 | 2/20 | 0.78 |
| ▸ | PRKCB | P05771 | 2/20 | 0.78 |
| ▸ | PRKCH | P24723 | 2/20 | 0.78 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.78 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.78 |
| ▸ | MEN1 | O00255 | 1/20 | 0.78 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.78 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1680253 | 1.00 | PRKD1 (1.00) | PRKD1TDP1PRKACAPRKACGPRKACB | |
| SCHEMBL29353099 | 1.00 | PRKD1 (1.00) | PRKD1TDP1PRKACAPRKACGPRKACB | |
| SCHEMBL29041083 | 0.96 | PRKD1 (0.92) | PRKD1TDP1PRKACAPRKACGPRKACB | |
| SCHEMBL9085119 | 0.95 | PRKD1 (0.90) | PRKD1TDP1PRKACAPRKACGPRKACB | |
| SCHEMBL7814801 | 0.94 | PRKD1 (0.88) | PRKD1TDP1PRKACAPRKACGPRKACB | |
| SCHEMBL7823817 | 0.93 | PRKD1 (0.87) | PRKD1TDP1PRKACAPRKACGPRKACB | |
| SCHEMBL9086159 | 0.93 | PRKD1 (0.87) | PRKD1TDP1PRKACAPRKACGPRKACB | |
| SCHEMBL7815373 | 0.91 | PRKD1 (0.84) | PRKD1TDP1PRKACAPRKACGPRKACB | |
| SCHEMBL9085659 | 0.89 | PRKD1 (0.81) | PRKD1TDP1PRKACAPRKACGPRKACB | |
| SCHEMBL9083990 | 0.89 | PRKD1 (0.81) | PRKD1TDP1PRKACAPRKACGPRKACB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230201173-A1 | SMAD4 Complex Inducers and Uses in Cancer Therapy | UNIV EMORY (US) | 2023-06-29 | — | — | US | claimed |
| WO-2022098110-A1 | PHARMACEUTICAL COMPOSITION FOR TREATING DEGENERATIVE BRAIN DISEASE, INCLUDING NEURAL PRECURSOR CELLS DERIVED FROM PLURIPOTENT STEM CELLS | (주) 에스바이오메딕스 | 2022-05-12 | — | — | WO | claimed |
| EP-4662319-A2 | PERSONALIZED CRISPR PROFILING FOR CANCER | Integrate Bioscience LLC (US) | 2025-12-17 | — | — | EP | disclosed |
| EP-3183336-B2 | RESETTING PLURIPOTENT STEM CELLS | CAMBRIDGE ENTPR LTD (GB) | 2025-07-09 | — | — | EP | disclosed |
| CN-119842617-A | Method for preparing retinal pigment epithelial cells | 住友制药株式会社 | 2025-04-18 | — | — | CN | disclosed |
| CN-119790139-A | Method for manufacturing primitive pluripotent stem cells | 国立大学法人京都大学 | 2025-04-08 | — | — | CN | disclosed |
| CN-110573610-B | Method for preparing retinal pigment epithelial cells | 住友制药株式会社 | 2025-01-28 | — | — | CN | disclosed |
| CN-119020268-A | Amniotic epithelial cell culture medium and culture method | 西安东澳生物科技有限公司 | 2024-11-26 | — | — | CN | disclosed |
| WO-2024168301-A2 | PERSONALIZED CRISPR PROFILING FOR CANCER | FUNCTION ONCOLOGY, INC. (US) | 2024-08-15 | — | — | WO | disclosed |
| WO-2024048731-A1 | METHOD FOR PRODUCING NAÏVE PLURIPOTENT STEM CELLS | 国立大学法人京都大学 | 2024-03-07 | — | — | WO | disclosed |
| EP-4251739-A1 | INDUCED STEM CELLS | Monash University (AU) | 2023-10-04 | — | — | EP | disclosed |
| US-20230201173-A1 | SMAD4 Complex Inducers and Uses in Cancer Therapy | UNIV EMORY (US) | 2023-06-29 | — | — | US | disclosed |
| EP-4168536-A1 | METHODS AND COMPOSITIONS FOR CULTIVATING PLURIPOTENT CELL SUSPENSIONS | Life Technologies Corporation (US) | 2023-04-26 | — | — | EP | disclosed |
| WO-2023017806-A1 | METHOD FOR PRODUCING PLURIPOTENT STEM CELLS | 株式会社カネカ | 2023-02-16 | — | — | WO | disclosed |
| WO-2022211486-A1 | COMPOSITION FOR PREVENTING, TREATING, OR AMELIORATING VIRAL INFECTIOUS DISEASES, COMPRISING CYTOKINE INHIBITOR, ACTIVE OXYGEN PRODUCTION INHIBITOR, AND SCAVENGER COMPLEX AS ACTIVE INGREDIENTS | 주식회사 소젠 | 2022-10-06 | — | — | WO | disclosed |
| CN-115135755-A | Method for inhibiting differentiation of pluripotent stem cells | 株式会社钟化 | 2022-09-30 | — | — | CN | disclosed |
| WO-2022191335-A1 | METHOD FOR INDUCING PRIMED PLURIPOTENT STEM CELLS INTO NAIVE PLURIPOTENT STEM CELLS, METHOD FOR MANUFACTURING NAIVE PLURIPOTENT STEM CELLS, KIT FOR NAIVE PLURIPOTENT STEM CELL INDUCTION, AND NAIVE PLURIPOTENT STEM CELL INDUCING AGENT | 国立大学法人京都大学 | 2022-09-15 | — | — | WO | disclosed |
| WO-2022178986-A1 | METHOD AND DRUG FOR INDUCING DIFFERENTIATION OF STEM CELLS INTO MESODERM LINEAGE OR TROPHOBLAST LINEAGE | 澳门大学 | 2022-09-01 | — | — | WO | disclosed |
| WO-2022109666-A1 | INDUCED STEM CELLS | MONASH UNIVERSITY (AU) | 2022-06-02 | — | — | WO | disclosed |
| WO-2022098110-A1 | PHARMACEUTICAL COMPOSITION FOR TREATING DEGENERATIVE BRAIN DISEASE, INCLUDING NEURAL PRECURSOR CELLS DERIVED FROM PLURIPOTENT STEM CELLS | (주) 에스바이오메딕스 | 2022-05-12 | — | — | WO | disclosed |